Besides higher CCR1, CCR2, and CCR4 (that bind CCL2 and CCL5), we found that CXCR3 (receptor for CXCL10) was also increased on OCPs in patients with RA (median 43.1% [IQR 33.3–54.2] in CTRL vs 61.5% [IQR 53.3–69.2] in RA, p = 0.009). This evidence concerns the gene CCL5 and rheumatoid arthritis.